Orally bioavailable beta 3-adrenergic receptor agonists as potential therapeutic agents for obesity and type-II diabetes
- Prog Med Chem. 2003:41:167-94. doi: 10.1016/s0079-6468(02)41005-3.
Affiliations
- 1. Wyeth Research, P.O. Box 42528, Philadelphia, PA 19101, USA.
PMID: 12774694
DOI: 10.1016/s0079-6468(02)41005-3
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Adrenergic ReceptorResearch Areas: Metabolic Disease